tiprankstipranks
Advertisement
Advertisement
Biodesix raises FY26 revenue view to $108M-$114M from $106M-$112M
PremiumThe FlyBiodesix raises FY26 revenue view to $108M-$114M from $106M-$112M
12d ago
BDSX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
BDSX Earnings this Week: How Will it Perform?
15d ago
Eight option delistings on April 20th
Premium
The Fly
Eight option delistings on April 20th
27d ago
Biodesix: Accelerating Growth, First Positive EBITDA, and Strengthening Risk‑Reward Support Buy Rating
PremiumRatingsBiodesix: Accelerating Growth, First Positive EBITDA, and Strengthening Risk‑Reward Support Buy Rating
3M ago
Biodesix upgraded to Outperform from Market Perform at William Blair
Premium
The Fly
Biodesix upgraded to Outperform from Market Perform at William Blair
3M ago
Biodesix sees FY26 revenue $106M-$112M, consensus $105.9M
Premium
The Fly
Biodesix sees FY26 revenue $106M-$112M, consensus $105.9M
3M ago
Biodesix trading halted, volatility trading pause
PremiumThe FlyBiodesix trading halted, volatility trading pause
4M ago
Biodesix sees Q4 revenue $28.8M, consensus $25.02M
Premium
The Fly
Biodesix sees Q4 revenue $28.8M, consensus $25.02M
4M ago
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth
Premium
Company Announcements
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100